Loading…
Scilex Holding Co Is Focused On Acquiring, Developing And Commercializing Non-Opioid Pain Management Products For The Treatment Of Acute And Chronic Pain. It Targets Indications With High Unmet Needs And Large Market Opportunities With Non-Opioid Therapies For The Treatment Of Patients With Acute And Chronic Pain And Are Dedicated To Advancing And Improving Patient Outcomes. Its Commercial Products Are: Ztlidoo For The Relief Of Neuropathic Pain Associated With Postherpetic Neuralgia (Phn), Which Is A Form Of Post-Shingles Nerve Pain; Elyxyb, A Potential First-Line Treatment Ready-To-Use Oral Solution For The Acute Treatment Of Migraine In Adults And Gloperba, The Liquid Oral Version Of The Anti-Gout Medicine Colchicine Indicated For The Prophylaxis Of Painful Gout Flares In Adults.